The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
Help: Registration number
ACTRN12626001153303p
Ethics application status
Help: Ethics application status
Not yet submitted
Date submitted
Help: Date submitted
10/07/2026
Date registered
Help: Date registered
16/09/2026
Date last updated
Help: Date last updated
16/09/2026
Date data sharing statement initially provided
Help: Data sharing statement date
16/09/2026
Type of registration
Help: Type of registration
Prospectively registered

Titles & IDs
Public title
Pilates exercise for adults with advanced cancer: A pilot study evaluating feasibility, safety and effectiveness.
Scientific title
The feasibility and efficacy of Pilates exercise in people diagnosed with advanced cancer: A pilot randomised waitlist control trial.
Additional trial identifiers [1] 317811 0
Nil
Universal Trial Number (UTN)
Trial acronym
Related trial records

Health condition
Health condition(s) studied:
Advanced Cancer 342744 0
Metastatic Cancer 342745 0
Condition category
Condition code
Cancer 338876 338876 0 0
Any cancer
Physical Medicine / Rehabilitation 339024 339024 0 0
Other physical medicine / rehabilitation

Intervention/exposure
Study type
Interventional
Description of the intervention or exposure
Intervention group: Pilates Exercise Program
Participants allocated to the intervention group will undertake an 8-week supervised Pilates mat-based exercise program delivered by an accredited exercise physiologist who is also a certified Pilates instructor. The Pilates intervention will comprise:
2 supervised Pilates sessions per week for 8 weeks, 60 minutes per session, 1 face-to-face session weekly, and 1 telehealth session weekly. Small group format (approx. 3–5 participants per class). Delivered at Southern Cross University, and online via telehealth. Exercises will be individualised and modified according to participant ability, symptoms, and safety, and progression is individualised. Exercise intensity will be monitored through Rating of Perceived Exertion (RPE). Symptom monitoring adherence and compliance will be monitored (i.e., session attendance, drop out, drop out reason, and study completion rate). Any adverse events will be graded using the Common Terminology Criteria for Adverse Events (CTCAE) V6.0 (National Cancer Institute, 2017) and reported. Examples of Pilates exercises that will be prescribed as part of the intervention include: Bridging, dead bugs, arm arcs, chest lift, side to side, book openings, prone spine extension, quadruped and standing roll down.
Intervention code [1] 334659 0
Rehabilitation
Intervention code [2] 334660 0
Lifestyle
Intervention code [3] 334661 0
Treatment: Other
Description of the comparator or control
Usual care / waitlist control group: Will continue their usual care for the 8-week trial period. The usual care group will receive no Pilates or exercise intervention during the 8-week trial period. Following the initial Pilates 8-week intervention period, the usual care (control) group will be offered the same 8-week Pilates intervention contingent on demonstration of feasibility and safety.
Control group
Active

Outcomes
Primary outcome [1] 346126 0
Feasibility of the Pilates intervention.
Timepoint [1] 346126 0
Throughout recruitment and intervention period; assessed continuously and summarised at study completion.
Primary outcome [2] 346269 0
Safety of the Pilates intervention.
Timepoint [2] 346269 0
Recorded throughout the intervention period at every Pilates intervention session and whenever an adverse event occurs.
Secondary outcome [1] 464803 0
Physical Function: Grip Strength test
Timepoint [1] 464803 0
Pilates and Usual Care Group: Baseline and post-completion of final session. Pilates group only: Follow-up (8 weeks post-completion of final session).
Secondary outcome [2] 464804 0
Lower body strength / function
Timepoint [2] 464804 0
Pilates and Usual Care Group: Baseline and post-completion of final session. Pilates group only. Follow-up (8 weeks post-completion of final session).
Secondary outcome [3] 464806 0
Dynamic Balance and Mobility (composite outcome)
Timepoint [3] 464806 0
Pilates and Usual Care Group: Baseline and post-completion of final session. Pilates group only: Follow-up (8 weeks post-completion of final session).
Secondary outcome [4] 464807 0
Static Balance
Timepoint [4] 464807 0
Pilates and Usual Care Group: Baseline and post-completion of final session. Pilates group only: Follow-up (8 weeks post-completion of final session).
Secondary outcome [5] 464808 0
Physical Activity
Timepoint [5] 464808 0
Pilates and Usual Care Group: Baseline and post-completion of final session. Pilates group only; Follow-up (8 weeks post-completion of final session).
Secondary outcome [6] 464809 0
Psychosocial Outcomes Quality of Life
Timepoint [6] 464809 0
Pilates and Usual Care Group: Baseline and post-completion of final session. Pilates group only, follow-up (8 weeks post-completion of final session).
Secondary outcome [7] 464810 0
Sleep Quality
Timepoint [7] 464810 0
Pilates and Usual Care Group: Baseline and post-completion of final session. Pilates group only, follow-up (8 weeks post-completion of final session).
Secondary outcome [8] 465269 0
Safety
Timepoint [8] 465269 0
At each Pilates session, ad hoc at the time of the adverse event.

Eligibility
Key inclusion criteria
- Adults aged 18 years and older
- Confirmed diagnosis of advanced cancer
- Not participating in structured exercise greater than or equal to twice/week during previous 3 months
- Able to attend Southern Cross University at least once weekly
- Medical clearance to undertake Pilates exercise intervention
- Adequate English language skills
- Capacity to provide informed consent
- Access to a device capable of telehealth participation
- Participants receiving active cancer treatment or not on treatment are eligible
Minimum age
18 Years
Maximum age
No limit
Sex
Both males and females
Healthy volunteers
No
Key exclusion criteria
- Inability to understand study procedures or provide informed consent
- Contraindications to exercise determined by treating clinician
- Severe cardiovascular, musculoskeletal or medical conditions precluding participation
- ECOG performance status > 2
- CTCAE > Grade 2
- Current moderate-to-severe bone pain
- Already achieving recommended cancer-specific exercise levels

Study design
Purpose of the study
Treatment
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Sequentially numbered opaque sealed envelopes prepared by an independent researcher.
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Computer-generated random allocation sequence prepared by an independent researcher not involved in recruitment or intervention delivery.
Masking / blinding
Open (masking not used)
Who is / are masked / blinded?



Intervention assignment
Other design features
Phase
Not Applicable
Type of endpoint/s
Safety/efficacy
Statistical methods / analysis
Sample size required to address the feasibility study aims and objectives is based on the evidence from the systematic review findings conducted by the SCU research team, RCT studies total sample sizes ranged from 28 to 110 participants, with Pilates group sample sizes ranging from 9 to 36 participants. The feasibility trial sample size is consistent with Montgomery's (2025) suggestions that feasibility trial sample sizes mirror what is done in RCTs, and define outcomes and progression criteria (i.e., recruitment, retention, adherence rates and implementation) to justify planning a future definitive trial (Montgomery, 2025). Based on this evidence the total sample size for this feasibility study will be 20 – 30 participants.

Recruitment
Recruitment status
Not yet recruiting
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
NSW,QLD

Funding & Sponsors
Funding source category [1] 322356 0
Self funded/Unfunded
Name [1] 322356 0
Country [1] 322356 0
Primary sponsor type
University
Name
Southern Cross University
Address
Country
Australia
Secondary sponsor category [1] 325668 0
None
Name [1] 325668 0
Address [1] 325668 0
Country [1] 325668 0

Ethics approval
Ethics application status
Not yet submitted
Ethics committee name [1] 320859 0
North Coast NSW Human Research Ethics Committee
Ethics committee address [1] 320859 0
Ethics committee country [1] 320859 0
Australia
Date submitted for ethics approval [1] 320859 0
22/10/2026
Approval date [1] 320859 0
Ethics approval number [1] 320859 0

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 151858 0
Dr Carmen Hansen
Address 151858 0
Tweed Valley Hospital, 771 Cudgen Road, Cudgen, NSW 2487
Country 151858 0
Australia
Phone 151858 0
+61402424504
Fax 151858 0
Email 151858 0
Contact person for public queries
Name 151859 0
Rachel Scicluna
Address 151859 0
Southern Cross University Gold Coast. Southern Cross Drive, Bilinga QLD 4225, Australia
Country 151859 0
Australia
Phone 151859 0
+61402424504
Fax 151859 0
Email 151859 0
Contact person for scientific queries
Name 151860 0
Rachel Scicluna
Address 151860 0
Southern Cross University Gold Coast. Southern Cross Drive, Bilinga QLD 4225, Australia
Country 151860 0
Australia
Phone 151860 0
+61402424504
Fax 151860 0
Email 151860 0

Data sharing statement
Will the study consider sharing individual participant data?
No
No IPD sharing reason/comment: Individual participant data will not be publicly available due to ethical and privacy considerations associated with a small clinical population; however, aggregate results will be reported through publications and presentations.



What supporting documents are/will be available?

TypeCitationLinkEmailOther DetailsAttachment
Study protocol  [email protected] NNSWLHD Pilates and Cancer Feasibility Study Protocol_V8.docx


Results publications and other study-related documents

Documents added manually
TypeIs Peer Reviewed?DOICitations or Other DetailsAttachment
ProtocolNo Study Protocol NNSWLHD Pilates and Cancer Feasibility Study Protocol_V8.docx

Documents added automatically
No additional documents have been identified.